Leadership History

CVS Health: CEO History

4 leaders · 1998 to present

Company Overview

CVS Health combines a retail pharmacy footprint, one of the largest PBMs, a major insurer, and care delivery assets. The model is powerful but operationally hard because small margin shifts across insurance or pharmacy can move billions of dollars.

4

David Joyner

President, Chief Executive Officer and Chair

2024 – 2024

0 years

Legacy

Joyner leads the post-2024 execution reset, emphasizing Caremark discipline, Aetna recovery, pharmacy reimbursement change, and integrated care outcomes. Joyner, who holds a business administration degree from Texas Tech University, spent 37 years in healthcare and pharmacy-benefit management, beginning at Aetna before joining Caremark, and rose through sales and account-management leadership at CVS Caremark before becoming CEO in October 2024, succeeding Karen Lynch. His appointment came amid investor pressure over CVS Health's underperforming stock and concerns about the profitability of its Aetna insurance business, with the board seeking an operationally focused executive with deep pharmacy-benefit-management experience rather than an outside hire. He has prioritized restoring profitability in the Aetna insurance business by repricing Medicare Advantage plans and tightening cost controls, while also working to stabilize CVS's retail pharmacy footprint amid continued store closures across the industry. He continues to serve as CEO today.

3

Karen Lynch

President and Chief Executive Officer

2021 – Present

5 years (current)

Legacy

Led CVS through Oak Street Health and other care-delivery acquisitions, but departed during the 2024 Medicare Advantage underwriting crisis. Lynch, a Boston College and Boston University graduate who began her career as a CPA at Ernst & Young, became the first female president of Aetna in 2015 before CVS acquired Aetna in 2018. She became CVS Health CEO in February 2021, at the time the highest-ranking female CEO on the Fortune 500, and led the company until October 2024. During her tenure, CVS faced significant margin pressure in its Medicare Advantage insurance business due to higher-than-expected medical costs, a challenge that contributed to her departure and the board's decision to bring in Joyner's operational expertise. Before becoming CVS Health CEO, she also served as executive vice president of CVS Health starting in 2018, overseeing the integration of Aetna following its acquisition, giving her direct experience with the health-insurance business before leading the combined company. She also oversaw the continued rollout of CVS HealthHubs, in-store clinics offering expanded health services beyond traditional pharmacy counters, part of the company's broader strategy to position retail locations as primary-care access points.

2

Larry Merlo

President and Chief Executive Officer

2011 – 2021

10 years

Legacy

Led the Aetna acquisition and the 2014 removal of tobacco products as CVS repositioned itself as a health company. Merlo, a University of Pittsburgh pharmacy graduate, joined CVS in 1990 when it acquired his employer Peoples Drug, rising through store operations and pharmacy leadership before becoming CEO in March 2011. He led the company for nearly a decade, including its transformative 2018 acquisition of Aetna, before retiring in January 2021. He also oversaw CVS's controversial 2014 decision to stop selling tobacco products in its stores, forgoing an estimated $2 billion in annual revenue in a move the company framed as consistent with its healthcare-focused brand identity. Merlo also led CVS through its 2015 acquisition of Omnicare, a long-term-care pharmacy provider, and the 2015 acquisition of Target's pharmacy and clinic business, continuing the company's expansion beyond retail pharmacy into broader healthcare services during his decade as CEO. He retired from CVS in early 2021.

1

Thomas Ryan

President and Chief Executive Officer

1998 – 2011

13 years

Legacy

Oversaw national pharmacy expansion and the Caremark merger that created the PBM core of CVS Health. Ryan, a University of Rhode Island pharmacy graduate who began as an in-store CVS pharmacist in 1978, became CEO in 1998 (having been named president in 1994) and led the company for 13 years, during which CVS revenue grew from about $1 billion to $105 billion as he transformed it from a regional drugstore chain into a national pharmacy-services company. He also served on the boards of Yum! Brands (2002-2017), Bank of America, Five Below, and Reebok International across his career, and oversaw CVS's 2007 merger with Caremark, the pharmacy-benefit manager that became the foundation of CVS's later expansion into integrated healthcare services.

Challenges & Strategic Context

Key risks include PBM scrutiny, Medicare Advantage cost trends, retail pharmacy reimbursement pressure, care delivery profitability, goodwill impairments, and regulatory attention on vertical integration.

CVS Health CEO and Leadership FAQ

Who is the current chief executive officer of CVS Health Corp.?

Karen S. Lynch currently leads CVS Health Corp., overseeing strategic vision, balance sheet health, and organizational execution in Healthcare / Pharmacy Retail.

What is the CEO's primary strategic agenda for 2026?

Under executive direction, CVS Health Corp. is prioritizing workflow automation alongside disciplined capital allocation to maximize shareholder value.

How has executive leadership guided CVS Health Corp. through past market transitions?

Leadership at CVS Health Corp. has historically navigated industry cycles by restructuring operational priorities and expanding competitive moats.